Desyrel
Indicated to address depressive episodes and utilized to support sleep quality.
- Categories
- Antidepressants · Sleep Management
- Active ingredient
- Trazodone
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Tablet
- Strengths
- 25 · 50 · 100mg
Desyrel details
- Condition
- Major Depressive Disorder
- Alternative names
- Molipaxin
- Therapeutic class
- Antidepressant
- Pharmacological class
- SARI
- Known off-label uses
- insomnia
- Contraindications
- acute recovery phase of myocardial infarction
- Precautions and warnings
- avoid alcohol; risk of orthostatic hypotension
- Minor side effects
- drowsiness; dry mouth; dizziness
- Moderate side effects
- nausea; blurred vision
- Dosage forms
- Tablet
- Administration route
- Oral use
- Patient summary
- Indicated to address depressive episodes and utilized to support sleep quality.
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Sanofi
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- cns depressants; mao inhibitors
- Pregnancy and breastfeeding
- Consult your doctor.
Serious side effects
priapism, requires immediate medical attention; serotonin syndrome, requires immediate medical attention
Mechanism of action
Antidepressant that modulates serotonin levels in the brain. It acts as both a serotonin agonist, binding to receptors, and antagonist, blocking reuptake, helping to improve mood and sleep quality.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Desyrel
Desyrel is a recognised brand of Trazodone, an active ingredient used in clinical settings to support the management of Major Depressive Disorder. The same compound is also marketed under alternative names like Molipaxin. Produced by Sanofi, this medication comes in tablet form with available strengths of 25, 50, and 100mg.
Desyrel availability in Asia
Desyrel is a treatment registered across 13 markets, including Thailand, Malaysia and the Philippines, with availability also in Indonesia, Taiwan and South Korea. Generic Trazodone, often manufactured in India, offers a cost-effective alternative to the original brand for expats living in regions without immediate access to local stock. This treatment is best used under a doctor’s care to ensure appropriate management of the condition.